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Results from the Cystic Fibrosis 






























































Table 1. Adjusted Odds Ratio of Unmet Rx Need by Age of Person with CF	




Note: Odds ratios are adjusted to hold household income and insurance 
constant. *** Denotes there is a statistically significant association between 






















Table 2. Adjusted Odds Ratio of Unmet Rx Need by Insurance Type of Person with CF	
Insurance Type Adjusted Odds Ratio P-value 
Private (Reference) (Reference) 
Medicaid, CHIP, State Program 0.854 0.337 
Medicare 1.430 0.074 
Dual 0.715 0.290 
Note: Odds ratios are adjusted to hold age and household income constant. P-values suggest that the 

























































































































































Less than $30,000 $30,000-$59,999 $60,000- $119,999$120,000-$149,999$150,000 or more
Household Income
By Household Income






































Table 4. Adjusted Odds Ratio of Unmet Rx Need by Problems Paying for Medications or 
Supplements	
Financial Burden Adjusted Odds Ratio 
No problem paying for medications (Reference) 
Any problem paying for medications 6.343*** 
Note: Odds ratios are adjusted to hold insurance and household income constant. *** 































People with CF 
Percentage Who Had a 
Problem Paying for Care 
Center Visit, Among Those 
Who Delayed or Skipped 
Care Center Visit 
Percentage of Who Had 
Any Unmet Rx Need, 
Among Those Who 
Delayed or Skipped Care 
Center Visit 
Skipped routine CF care 
center visit(s) 10% 53% 68% 
 
Delayed CF care center 












Table 6. Adjusted Odds Ratio of Unmet Rx Need by Delays in Care Center Visits	
Care Center Access Adjusted Odds Ratio 
Routine Visit  
Did not skip (Reference) 
Skipped 7.128*** 
Sick Visit  
Did not delay (Reference) 
Delayed 6.664*** 
Note: Odds ratios are adjusted to hold insurance and household income 
constant. *** Denotes that statistically significant difference between the 
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Endnotes 
	
1	Sarnak	DO,	Squires	D,	Kuzmak	G,	Bishop	S.	Paying	for	Prescription	Drugs	Around	the	
World:	Why	Is	the	U.S.	an	Outlier?	The	Commonwealth	Fund.	
https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-
prescription-drugs-around-world-why-us-outlier	Published	2017	
2	The	survey	used	previously	validated	questions	from	national	surveys	related	to	unmet	
medical	need,	coverage,	access	to	care,	and	financial	hardship.	Some	questions	were	
modified	to	fit	the	CF	population’s	experience,	and	developed	new	CF-specific	questions	
about	services,	treatments,	and	supplies	with	input	from	CF	Foundation	staff	and	advisors.	
The	survey	also	included	questions	on	socio-demographic	characteristics,	general	health,	
CF-related	illness	and	challenges,	insurance	benefits	and	coverage,	access	to	care,	and	costs	
of	CF	care.		
3	Cystic	Fibrosis	Foundation	Patient	Registry	2019	Annual	Data	Report	Bethesda,	Maryland	
©2020	Cystic	Fibrosis	Foundation.	
4	People	with	CF	were	categorized	into	three	age	groups-	children	0-17	years	old,	young	
adults	18-35	years	old,	and	older	adults	36	years	and	above.	For	insurance,	we	identified	
six	unique	categories-	private,	Medicaid,	Medicare,	Duals,	other,	and	uninsured.		To	account	
for	people	with	multiple	insurance	types	we	identified	respondents	as	belonging	to	one	
insurance	category,	using	the	following	decision	criteria:		
• Medicaid:	Respondents	whose	coverage	is	Medicaid,	CHIP,	or	a	state	program.	The	
Medicaid	category	includes	respondents	with	any	of	these	programs	or	respondents	
with	other	sources	of	coverage	in	addition	to	Medicaid,	CHIP	or	a	state	program,	
except	for	respondents	with	Medicare,	who	are	otherwise	categorized	(see	below).		
• Medicare:	Respondents	whose	coverage	is	Medicare.	The	Medicare	category	
includes	respondents	with	Medicare	alone	or	with	any	additional	sources	of	
coverage,	except	for	respondents	with	Medicaid.		
• Duals:	Respondents	whose	coverage	includes	Medicare	and	Medicaid.	The	Duals	
category	includes	respondents	with	Medicare	and	Medicaid	only,	or	respondents	
with	Medicare,	Medicaid	and	additional	sources	of	coverage.	
• Private:	Respondents	whose	coverage	is	private.	The	private	category	includes	
participants	with	any	other	additional	sources	of	coverage,	except	for	Medicaid	
and/or	Medicare.		
• Other:	Respondents	whose	coverage	is	not	private,	Medicaid,	Medicare,	or	
uninsured.		
• Uninsured:	Respondents	who	report	they	do	not	have	insurance.	
5	Participants	were	asked	to	select	their	premiums,	deductibles,	and	other	out-of-pocket	
expenses	from	given	ranges.	For	each	expense	type,	an	upper	bound	was	not	specified.	
Instead,	respondents	were	able	to	select	some	value	“or	more”	as	an	option	(e.g.	“$20,00	or	
more”).	In	order	to	estimate	the	total	annual	cost	to	the	patient,	the	midpoint	of	each	range	
was	taken	and	summed	to	determine	an	estimated	annual	total	cost	to	the	patient.			
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https://www.pqaalliance.org/assets/Research/PQA-Access-to-Care-Report.pdf	
7	Mogayzel	PJ	Jr,	Dunitz	J,	Marrow	LC,	Hazle	LA.	Improving	chronic	care	delivery	and	
outcomes:	the	impact	of	the	cystic	fibrosis	Care	Center	Network.	BMJ	Qual	Saf.	2014;23	
Suppl	1:i3-i8.	doi:10.1136/bmjqs-2013-002363	
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